Nocturnal oxygen therapy as an option for early COVID-19
Chongxing Shen, Xiaofeng Yue, Jianwu Wang, Chunmeng Shi, Weibing Li
Abstract
There is currently no effective antiviral therapy or immune-based treatment for coronavirus disease (COVID-19). The urgent challenge is to prevent the transition of COVID-19 from mild to severe infection. This paper discussed nocturnal oxygen therapy as a new option for people with COVID-19 under home quarantine. It suggested that nocturnal oxygen therapy in the early stages may be helpful in preventing disease progression by inhibiting the rapid replication of the virus and improving the body's antiviral ability.
Topics & Concepts
Oxygen therapyCoronavirus disease 2019 (COVID-19)QuarantineNocturnalMedicineDiseaseAntiviral therapyCoronavirusIntensive care medicine2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusImmunologyVirologyInternal medicineInfectious disease (medical specialty)PathologyChronic hepatitisOutbreakLong-Term Effects of COVID-19Respiratory Support and MechanismsCOVID-19 Clinical Research Studies